Mark A. Prygocki Sr.
CIK: 0001257544
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRCA
Verrica Pharmaceuticals Inc.
Director
Discretionary Trading P&L
Holdings
About PRYGOCKI MARK A SR
PRYGOCKI MARK A SR (SEC CIK 0001257544) files insider reports with the SEC as Director of Verrica Pharmaceuticals Inc. (VRCA).
Signal8 holds 2 ownership filings by PRYGOCKI MARK A SR, all Form 4s, filed between Jun 9, 2025 and Jun 9, 2026. Those filings report 2 transactions, from Jun 5, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PRYGOCKI MARK A SR's filings is in WEST CHESTER, PA.
Recent filings by PRYGOCKI MARK A SR
Other insiders filing for Verrica Pharmaceuticals Inc. (VRCA)
- Zawitz David, Chief Operating Officer
- Rieger Jayson, CEO and President
- Rosenberg Noah L., CMO
- Kirby John J., Interim CFO
- Eichenfield Lawrence, Director
- Nguyen Diem, Director